.

Phosphoinositide Biology: New Therapeutic Targets Beyond 2018

Sun, February 11 - Thu, February 15, 2018 Taos, New Mexico
Sagebrush Inn & Suites 1508 Paseo Del Pueblo Sur Taos, New Mexico 87571 United States +1 575-758-2254

About Phosphoinositide Biology: New Therapeutic Targets Beyond 2018

PHOSPHOINOSITIDE BIOLOGY: NEW THERAPEUTIC TARGETS BEYOND, TAOS, FEBRUARY 11-15, 2018

Phosphoinositides have been recognized since the 1980s as important regulatory lipids supporting signal transduction from G protein-coupled receptors and receptor tyrosine kinases. The discovery of PI 3-kinases and their roles in carcinogenesis and immune regulation has created a fertile ground for translational expansion of the phosphoinositide field with a focus on cancer and inflammation. Most of these advances focused on Class I PI3Ks and PIP3-mediated signaling. However, research on other PI kinases and phosphoinositides has expanded substantially over the years. Class II and -III PI 3-kinases and less characterized 3-phosphorylated phosphoinositides are now rapidly emerging as key controllers of development, trafficking, nutrition-sensing and autophagy. Furthermore, phosphoinositides different from the 3-phosphorylated species are gaining momentum in many aspects of cell physiology and pathology. Exciting new developments include PI 4-kinases controlling vesicular trafficking and non-vesicular lipid transfer between membrane contacts, and new details are emerging on the role of inositol lipid phosphatases in trafficking, endocytosis and ciliary function. The recently recognized roles of PI 4-kinases as obligate host factors for certain RNA viruses, and their importance in parasitic organisms such as Plasmodium falciparum or Legionella pneumophila, have raised significant interest from pharmaceutical companies that now focus on inositol lipids other than the products of PI 3-kinases. By expanding our knowledge of phosphoinositides beyond class I PI3K products, this Keystone Symposia meeting represents a unique opportunity to bolster the rising interest in these under-explored avenues with a strong potential for translational impact.

Event Highlights:

  • Phosphoinositide Gradients and Lipid Transport at Membrane Contact Sites
  • PI 4-Kinases as Possible Drug Targets
  • Inositide Phosphatases in Cancer and Development
  • New and Emerging Paradigms and Possible Drug Targets
  • Structural Insights into Pharmacological Targeting of Lipid Kinases
  • Phosphoinositides Directing Trafficking for Degradation
  • Monoinositide Phosphatases

No reviews for "Phosphoinositide Biology: New Therapeutic Targets Beyond 2018" yet. Be the first!

Add New Review

No Thanks

Event Listing Options

FREE per event
  • Event listing with basic details
  • Event details curated from 3rd party data or event's own website
$300 per event
  • Enhanced search listing (30 days)
  • Super-sized event tile (30 days)
  • Enhanced keywords and description for search engine optimization
  • Already boosted? Boost an additional 30 days!
$600 per event
  • Enhanced search listing (30 days)
  • Super-sized event tile (30 days)
  • Enhanced keywords and description for search engine optimization
  • Enhanced event listing features: Includes video display, 4 key sponsors and back-linking to them, 4 key speakers and back-linking to them, ticket sales capability.
$1000 per event
  • Enhanced search listing (30 days)
  • Super-sized event tile (30 days)
  • Enhanced keywords and description for search engine optimization
  • Enhanced event listing features: Includes video display, 4 key sponsors and back-linking to them, 4 key speakers and back-linking to them, ticket sales capability.
  • Pick one of the following: Social media callout on CN owned channel, listing in a CN special report, (1) 600-800 word blog post on CN's blog.

Multiple listings? Every 6th listing is free.

A la carte:

$500each

  • 600-800 word blog post on CN's blog
  • Social media callout on CN owned channel
  • Listing in a CN special report

Event Information Edit Suggestion